Expression analysis detected HMGA1-high cancer cells (HMGA1 expression level>2), CD44-high cancer cells (CD44 expression level>2) and double-positive cancer cells in the integrated TNBC cohorts (Fig. 5C,D; Fig. S5B). The gene discussed is CD44; the disease is cancer.